{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:16Z","timestamp":1793600836445,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ophtha.2026.03.009","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T16:17:10Z","timestamp":1773245830000},"page":"829-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of Intravitreal Anti\u2013VEGF Injections on Cataract Development"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2144-3989","authenticated-orcid":false,"given":"Jaehwan","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Woong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungsoon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6259-6485","authenticated-orcid":false,"given":"Hwanho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ophtha.2026.03.009_bib1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s00417-017-3647-4","article-title":"Fundamental principles of an anti-VEGF treatment regimen: optimal application of intravitreal anti-vascular endothelial growth factor therapy of macular diseases","volume":"255","author":"Lanzetta","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"14","key":"10.1016\/j.ophtha.2026.03.009_bib2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ophtha.2026.03.009_bib3","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"issue":"10326","key":"10.1016\/j.ophtha.2026.03.009_bib4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ophtha.2026.03.009_bib5","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/bjo-2025-327776","article-title":"Global trends in cataract burden: a 30-year epidemiological analysis and prediction of 2050 from the Global Burden of Disease 2021 study","volume":"110","author":"Jiang","year":"2026","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2026.03.009_bib6","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.ophtha.2011.03.032","article-title":"Risk factors associated with incident cataracts and cataract surgery in the Age-Related Eye Disease Study (AREDS): AREDS report number 32","volume":"118","author":"Chang","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2026.03.009_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ajo.2005.11.050","article-title":"Cataract formation and other complications of intravitreal triamcinolone for macular edema","volume":"141","author":"Thompson","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2026.03.009_bib8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ophtha.2013.07.015","article-title":"United Kingdom National Ophthalmology Database study of vitreoretinal surgery: report 3, retinal detachment","volume":"121","author":"Jackson","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.03.009_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ajo.2023.06.021","article-title":"Incidence of and risk factors for cataract in anterior uveitis","volume":"254","author":"Papaliodis","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2026.03.009_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ophtha.2024.08.022","article-title":"MERLIN: two-year results of brolucizumab in participants with neovascular age-related macular degeneration and persistent retinal fluid","volume":"132","author":"Brown","year":"2025","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2026.03.009_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajo.2014.06.019","article-title":"Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes","volume":"158","author":"Goldberg","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2026.03.009_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/ICU.0000000000000154","article-title":"Ocular inflammation associated with antivascular endothelial growth factor treatment","volume":"26","author":"Fine","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2026.03.009_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/aos.15089","article-title":"Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysis","volume":"100","author":"Bjerager","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2026.03.009_bib14","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bjophthalmol-2020-318645","article-title":"Risk model for intraoperative complication during cataract surgery based on data from 900 000 eyes: previous intravitreal injection is a risk factor","volume":"106","author":"H\u00e5rd Af Segerstad","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2026.03.009_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ophtha.2015.06.040","article-title":"Effect of prior anti-VEGF injections on the risk of retained lens fragments and endophthalmitis after cataract surgery in the elderly","volume":"123","author":"Hahn","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ophtha.2026.03.009_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.oret.2019.01.018","article-title":"Long-term outcome of intravitreal aflibercept treatment for neovascular age-related macular degeneration using a \u201ctreat-and-extend\u201d regimen","volume":"3","author":"Traine","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"2","key":"10.1016\/j.ophtha.2026.03.009_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00417-020-04932-0","article-title":"Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study","volume":"259","author":"Costa","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2026.03.009_bib18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archopht.1993.01090060119035","article-title":"The lens opacities classification system III. The Longitudinal Study of Cataract Study Group","volume":"111","author":"Chylack","year":"1993","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2026.03.009_bib19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/archopht.119.10.1475","article-title":"Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography","volume":"119","author":"Uchino","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ophtha.2026.03.009_bib20","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/IAE.0b013e3181a94f01","article-title":"Intravitreal injection of therapeutic agents","volume":"29","author":"Peyman","year":"2009","journal-title":"Retina"},{"issue":"408","key":"10.1016\/j.ophtha.2026.03.009_bib21","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the Cox proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.ophtha.2026.03.009_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.oret.2024.07.024","article-title":"Efficacy and safety of anti-VEGF injections and surgery for age-related macular degeneration-related submacular hemorrhage: a systematic review and meta-analysis","volume":"9","author":"Shaheen","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ophtha.2026.03.009_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106904","article-title":"Anti-VEGF combined with ocular corticosteroids therapy versus anti-VEGF monotherapy for diabetic macular edema focusing on drugs injection times and confounding factors of pseudophakic eyes: a systematic review and meta-analysis","volume":"196","author":"Chen","year":"2023","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.ophtha.2026.03.009_bib24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/jop.2010.0045","article-title":"Incidence of damage to the crystalline lens during intravitreal injections","volume":"26","author":"Meyer","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ophtha.2026.03.009_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3928\/01913913-20190211-02","article-title":"Iatrogenic crystalline lens injury in pediatric eyes following intravitreal injection for retinopathy of prematurity","volume":"56","author":"Vanathi","year":"2019","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"2","key":"10.1016\/j.ophtha.2026.03.009_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ceo.13892","article-title":"Cataract and systemic disease: a review","volume":"49","author":"Ang","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2026.03.009_bib27","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2021.10.006","article-title":"Cataract in the adult eye Preferred Practice Pattern","volume":"129","author":"Miller","year":"2022","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ophtha.2026.03.009_bib28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ophtha.2015.10.028","article-title":"Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis","volume":"123","author":"Dick","year":"2016","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ophtha.2026.03.009_bib29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2006.02.021","article-title":"Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study","volume":"113","author":"Jaffe","year":"2006","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ophtha.2026.03.009_bib30","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ophtha.2020.11.011","article-title":"Risk of inflammation, retinal vasculitis, and retinal occlusion-related events with brolucizumab: post hoc review of HAWK and HARRIER","volume":"128","author":"Mon\u00e9s","year":"2021","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ophtha.2026.03.009_bib31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/jcm10050981","article-title":"Inflammatory complications of intravitreal anti-VEGF injections","volume":"10","author":"Cox","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ophtha.2026.03.009_bib32","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/IAE.0000000000000398","article-title":"Frequency and characteristics of intraocular inflammation after aflibercept injection","volume":"35","author":"Fine","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2026.03.009_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/928123","article-title":"Sterile endophthalmitis after intravitreal injections","volume":"2012","author":"Marticorena","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ophtha.2026.03.009_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.exer.2012.05.007","article-title":"Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation","volume":"101","author":"Zhang","year":"2012","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.ophtha.2026.03.009_bib35","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.exer.2008.08.001","article-title":"Synergistic effect of osmotic and oxidative stress in slow-developing cataract formation","volume":"87","author":"Chan","year":"2008","journal-title":"Exp Eye Res"},{"issue":"10","key":"10.1016\/j.ophtha.2026.03.009_bib36","first-page":"1250","article-title":"Causative and preventive action of calcium in cataracto-genesis","volume":"25","author":"Gupta","year":"2004","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"10.1016\/j.ophtha.2026.03.009_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7150\/ijms.1.165","article-title":"Comparative study of serum Na(+)and K(+) levels in senile cataract patients and normal individuals","volume":"1","author":"Mirsamadi","year":"2004","journal-title":"Int J Med Sci"},{"issue":"5 Suppl","key":"10.1016\/j.ophtha.2026.03.009_bib38","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00006982-200410001-00002","article-title":"Evolving guidelines for intravitreous injections","volume":"24","author":"Aiello","year":"2004","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ophtha.2026.03.009_bib39","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/ceo.12732","article-title":"Biochemical analysis of the living human vitreous","volume":"44","author":"Kokavec","year":"2016","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.03.009_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40942-017-0097-4","article-title":"Correction to: pH of anti-VEGF agents in the human vitreous: low impact of very different formulations","volume":"3","author":"Sobolewska","year":"2017","journal-title":"Int J Retina Vitreous"},{"issue":"7","key":"10.1016\/j.ophtha.2026.03.009_bib41","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00417-013-2266-y","article-title":"Posterior vitreous detachment following intravitreal drug injection","volume":"251","author":"Geck","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2026.03.009_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1167\/iovs.03-0820","article-title":"Importance of vitreous liquefaction in age-related cataract","volume":"45","author":"Harocopos","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ophtha.2026.03.009_bib43","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.2147\/OPTH.S537700","article-title":"Cataract induced by glucocorticoids","volume":"19","author":"Jian","year":"2025","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.ophtha.2026.03.009_bib44","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1080\/09553002.2020.1812759","article-title":"Etiology of posterior subcapsular cataracts based on a review of risk factors including aging, diabetes, and ionizing radiation","volume":"96","author":"Richardson","year":"2020","journal-title":"Int J Radiat Biol"},{"issue":"4","key":"10.1016\/j.ophtha.2026.03.009_bib45","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1167\/iovs.06-0889","article-title":"Specific activation of the glucocorticoid receptor and modulation of signal transduction pathways in human lens epithelial cells","volume":"48","author":"Gupta","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2026.03.009_bib46","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1111\/j.1755-3768.2011.02292.x","article-title":"Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion","volume":"90","author":"Koss","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ophtha.2026.03.009_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12886-019-1278-8","article-title":"Comparison of cytokine levels in the aqueous humor of polypoidal choroidal vasculopathy and neovascular age-related macular degeneration patients","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"10.1016\/j.ophtha.2026.03.009_bib48","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1167\/iovs.10-6299","article-title":"Multivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatment","volume":"52","author":"Kaneda","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ophtha.2026.03.009_bib49","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1016\/j.ophtha.2016.09.027","article-title":"Cataract in the adult eye Preferred Practice Pattern\u00ae","volume":"124","author":"Olson","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2026.03.009_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109162","article-title":"Quantitative pharmacokinetic analyses of anterior and posterior elimination routes of intravitreal anti-VEGF macromolecules using published human and rabbit data","volume":"222","author":"Lamminsalo","year":"2022","journal-title":"Exp Eye Res"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026001582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026001582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:36:20Z","timestamp":1793597780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642026001582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0161642026001582"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.03.009","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Intravitreal Anti\u2013VEGF Injections on Cataract Development","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}